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Introduction {#sec001}
============

There is an increasing need to evaluate health-related aspects (i.e., biomarkers) that can be modified by regular physical exercise \[[@pone.0206307.ref001]\] to provide new evidence and strategies to achieve healthy aging \[[@pone.0206307.ref002]\]. Aging phenomena are linked with an increased risk of cognitive dysfunction \[[@pone.0206307.ref003]\] and chronic diseases \[[@pone.0206307.ref004]\], among other issues. Both factors contribute to changes in motor function and impairments in physical performance in the older adult population. These changes could affect the ability to perform daily activities in this type of population \[[@pone.0206307.ref005]\].

The pro-healthy effects of regular physical activity (PA) are well-documented \[[@pone.0206307.ref006],[@pone.0206307.ref007]\], and previous studies have revealed that physical fitness (PF) is a crucial independent predictor of mortality \[[@pone.0206307.ref008],[@pone.0206307.ref009]\]. Attributable risk estimates for all-cause mortality show that low PF, principally low cardiorespiratory fitness and low muscular strength, is a significant risk factor in both sexes \[[@pone.0206307.ref009],[@pone.0206307.ref010]\]. PF mixes most of the body functions that are involved in the performance of daily PA \[[@pone.0206307.ref011]\]. Decreases in PF are related to several negative health effects \[[@pone.0206307.ref012]\], and biomarkers have been proposed as essential health markers to evaluate the effects of physical exercise on the human body \[[@pone.0206307.ref001],[@pone.0206307.ref013]\].

Vitamin deficiencies can cause disorders in behavior, cognitive and emotional status, and personality \[[@pone.0206307.ref014]\]. Concretely, epidemiologic data indicates that the prevalence of vitamin B~12~ deficiency is from 6% to 40% \[[@pone.0206307.ref015]\]. Additionally, the worldwide prevalence of pernicious anemia has been estimated to be 24% in older adults (aged over 65 years) \[[@pone.0206307.ref016]\]. B vitamins and high total homocysteine (tHcy) concentrations have been connected with cardiovascular disease (especially stroke) \[[@pone.0206307.ref017],[@pone.0206307.ref018]\], cognitive decline and dementia \[[@pone.0206307.ref014],[@pone.0206307.ref019],[@pone.0206307.ref020]\], fractures \[[@pone.0206307.ref016],[@pone.0206307.ref021]\] and mortality \[[@pone.0206307.ref022],[@pone.0206307.ref023]\]. Likewise, low vitamin D status may stimulate adipogenesis \[[@pone.0206307.ref024]\], resulting in further increases in adiposity. Low vitamin D concentrations are also linked with muscle pain, muscle weakness \[[@pone.0206307.ref025],[@pone.0206307.ref026]\] and poor PF in older adults \[[@pone.0206307.ref027]\].

High concentration of low lipoprotein density cholesterol (LDL-c) and low concentration of high lipoprotein density cholesterol (HDL-c) can increase the progression of coronary heart disease \[[@pone.0206307.ref028]\]. With increasing age, some changes in lipid and lipoprotein concentrations are overall unfavorable \[[@pone.0206307.ref029]\]. Furthermore, high cardiorespiratory fitness is related to a better blood lipid profile \[[@pone.0206307.ref029]\].

Through the analysis of different biomarkers, it could be possible to evaluate the reactions of the human body at several levels of PF \[[@pone.0206307.ref001]\]. However, research regarding the relationship between biomarkers and PF in the older adult population is still ongoing. Hence, the main purpose of this study was to investigate the relationship between blood biomarkers and PF groups associated with disease risk (more blood marker concentrations out of the reference range) in Spanish older adults.

Methods and materials {#sec002}
=====================

Study design, sample and ethics {#sec003}
-------------------------------

The PHYSMED project is a multicenter, cross-sectional study aiming to identify cardiovascular risk factors in sedentary and active older adult subjects. Data were collected from April 2013 to May 2014, and field work took place in 2 Spanish regions: Madrid and Balearic Island. Participants were recruited through health centers, sport federations, sport facilities and municipal clubs located in Madrid and Balearic Island following a snowball system. The study population included 429 adults (57% females) aged 55--88 years. The individual exclusion criteria were as follows: individuals younger than 55 years, those who were institutionalized, and those suffering from a physical or mental illness that would have limited their participation in the physical fitness tests or their ability to respond to the questionnaires or drug intake for clinical research. Each participant signed a written informed consent prior to his/her participation.

The study followed the Declaration of Helsinki 1964 and further amendments. Additionally, the protocol study was approved by the Ethical Committee of the Universidad Politécnica de Madrid.

Specimen collection and biochemical analyses {#sec004}
--------------------------------------------

Fasted (12 h) blood samples were collected from each participant, and lipid profiles and basic biochemical analyses were performed at the biochemical laboratories of the High Sports Council (Madrid) and Hospital Son Espases & University of Balearic Islands (Palma de Mallorca). The extraction was performed by standard venipuncture using vacuum Vacutainer tubes with separation gel. The tubes were immediately placed on ice, and after coagulum formation, the sample was centrifuged at 3,000 rpm for 10 minutes. Serum total cholesterol (TC), HDL-c, LDL-c, triglycerides (TG), glucose, urea, uric acid, total protein, albumin, glutamic oxalacetic transaminase, glutamic-pyruvic transaminase, gamma glutamyl transpeptidase, iron (FE) and ferritin (FER) were analyzed using a Beckman AU400 analyzer (Beckman AU400, Beckman Instruments, Ltd., Bucks, UK) by photometric methods. Creatinine was analyzed by a colorimetric method (Beckman AU400, Beckman Instruments, Ltd., Bucks, UK). Hematocrit and hemoglobin analyses were performed within the first hour after extraction in EDTA tubes using an automated hematology analyzer (ADVIA 120 Siemens Health Care Diagnostics, SA). These determinations were carried out in each site.

Vitamin B~12~, serum folate (sfolate), red blood cell folate (RBC folate, from EDTA tubes), vitamin D 25\[OH\]D and tHcy analyses were centralized at the High Sports Council Laboratory in Madrid. Therefore, serum samples from Palma de Mallorca were dry-ice shipped to Madrid and analyzed together with serum samples stored in Madrid at -80 °C, by an electrochemiluminescence method (Elecsys 2010, Roche Diagnostics, IN, USA), except vitamin D 25\[OH\]D, which was determined using an E411 analyzer (Roche Diagnostics, Switzerland).

Physical fitness tests {#sec005}
----------------------

Each participant completed a multicomponent battery of PF tests that have been validated in the older population \[[@pone.0206307.ref030]\] and in Spanish older adults proposed by Pedrero-Chamizo et al. \[[@pone.0206307.ref031]\]. Lower body strength was measured by the chair stand test, agility/dynamic balance was performed by the 8-foot up-and-go test, aerobic endurance was assessed by the 6-min walk test, and handgrip strength was measured with a handgrip dynamometer (Takei TKK 5401, Tokyo, Japan, range = 5--100 kg, precision = 0.1 kg) \[[@pone.0206307.ref032]\]. The handgrip strength was assessed for both hands in a standing position. All tests were performed twice, except the 6-min walk test and the chair stand test, and the best score was retained.

The results of each PF test were stratified by sex and five age groups \[divided by five-year periods, except the last group\] following the criteria established by Pedrero-Chamizo et al. \[[@pone.0206307.ref031]\]. The score for each test ranged from 0 (worst) to 3 (best) points. Thus, the maximum score was 12 points. The scores of the PF tests were added together to create a cluster. After that, to classify our population, the PF cluster was divided into 3 different groups: low, medium and high.

Anthropometric measurements {#sec006}
---------------------------

Weight, body mass index (BMI), total body water (TBW) and fat free mass (FFM) were measured using bioimpedance analysis (TANITA Corp, BC-418MA, Tokyo, Japan) in standardized conditions. Likewise, BMI was calculated as the weight (kg) divided by the square of the height (m). A trained anthropometrist according to the International Society measured waist and hip circumference for the Advancement of Kinanthropometry. Height was assessed to the nearest millimeter using a mobile stadiometer (SECA 213, Germany), with the participant's head in the Frankfurt plane.

Dietary assessment {#sec007}
------------------

Dietary intake was obtained by means of two 24-h dietary recalls collected on two nonconsecutive days within a period of 2--3 weeks by well-trained dieticians. A computer program was used to convert food into nutrients (ALIMENTA; NUCOX, Palma, Spain) based on Spanish \[[@pone.0206307.ref033],[@pone.0206307.ref034]\] and European \[[@pone.0206307.ref035]\] food composition tables and complemented with food composition data available for Majorcan food items \[[@pone.0206307.ref036]\].

Socioeconomic and lifestyle questionnaire {#sec008}
-----------------------------------------

A general questionnaire was used including smoking habits, and participants were grouped in categories as follows: (i) educational level: primary school, secondary school and college-level education; (ii) current income: \<600 €/month, 600--900€/month and ≥900 €/month; and (iii) smoker (≥1 cigarette/day) and nonsmoker.

Medication intake {#sec009}
-----------------

Participants were asked by means of the EXERNET questionnaire the following question: Do you regularly take drugs? (yes/no). If they answered yes, they were asked about type of medication, manufacturer, frequency of consumption and dose of each drug. Each drug was coded following the Spanish Agency of Medicines and Sanitary Products (<https://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=detalleForm>). Four groups of drug intake were considered: antidiabetics, renin-angiotensin system drugs, beta blockers and lipid-lowering drugs; all variables were grouped if participants took (coded as 1) or did not take each of the drugs (coded as 0).

Statistical analysis {#sec010}
--------------------

Statistics were performed using the statistical software SPSS (IBM Corp. Released 2012. Statistics for Window, V 21.0. Armonk, NY). Descriptive characteristics were summarized by calculating means and standard deviations unless otherwise stated. Each variable was checked for normality of distribution using the Kolmogorov-Smirnov test. The urea, uric acid, total protein, albumin, TC, HDL-c, LDL-c, hemoglobin, hematocrit and vitamin 25\[OH\]D concentrations showed a normal distribution. The differences between descriptive characteristics and sexes and the differences between biomarkers and PF groups were performed using a one-way ANOVA (for normally distributed variables) and the Kruskal-Wallis test (for nonnormally distributed variables). *Post hoc* analyses were conducted with the Bonferroni adjustment. All variables of the PF tests were checked for normality of distribution by the Kolmogorov-Smirnov test, and these presented a normal distribution.

Regarding vitamin D, the season and the date of blood sample collection were considered for statistical analysis. Samples collected from October to March were classified as "autumn-winter samples", and those collected from April to September were classified as "spring-summer samples". The latitudes of each city are similar: Mallorca (39° 34' N) and Madrid (40° 24' N).

Likewise, reference ranges established by each laboratory were used to categorize each biomarker as in or out of the reference range (See [S1 Table](#pone.0206307.s001){ref-type="supplementary-material"}). For vitamin B~12~ and related biomarkers, a different cut-off was applied \[[@pone.0206307.ref015]\]. Each biomarker within its reference range was coded as 1, and each biomarker out of its reference range was coded as 0.

The association between the status of each biomarker and the PF groups was assessed using the general lineal model. Each biomarker coded as 0 (out of the reference range) was used as a reference in this statistical model. The PF groups were used as an independent variable in which the high PF group was considered the reference. Depending on the biomarkers, drug intake was included into the model as an independent variable in which drug intake was the reference. Moreover, several diet covariables were considered depending on the biomarkers analyzed. The model was not considered when the level of significance of the omnibus test was higher than 0.05. In turn, the lower Akaike information criterion (AIC) was chosen in the final models. Albumin was not analyzed by means of the generalized linear model because only one participant presented abnormal concentrations. Values of p\<0.05 were considered statistically significant.

Results {#sec011}
=======

[Table 1](#pone.0206307.t001){ref-type="table"} includes the subjects' characteristics split by PF groups.

10.1371/journal.pone.0206307.t001

###### Descriptive characteristics of the studied sample split by PF groups.

![](pone.0206307.t001){#pone.0206307.t001g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                         Physical fitness groups                                                 
  -------------------------------------- ------------------------- ---------------------- ---------------------- ----------------------------------------------------------------------------------------------------------------------------------
  **Sex (female)**                       76 (58.6)                 98 (56.9)              70 (55.6)              \>0.05

  **Age (y)**                            66.8±7.1\                 66.6±6.6\              66.5±6.2\              \>0.05
                                         66.0 (55.0--87.8)         66.0 (55.0--85.4)      66.0 (55.1--80.8)      

  **City (Madrid)**                      30 (22.6)                 83 (47.7)              87 (69.0)              \>0.05

  **Height (cm)**                        161.2±8.8\                162.2±9.2\             163.9±8.9\             \<0.05[^b^](#t001fn003){ref-type="table-fn"}
                                         159.5 (143.0--183.0)      160.0 (142.0--184.0)   164.0 (145.5--185.5)   

  **Weight (kg)**                        72.4±13.5\                72.9±12.9\             69.1±11.4\             \<0.05[^c^](#t001fn004){ref-type="table-fn"}
                                         70.3 (44.9--116.6)        71.5 (44.0--99.5)      68.2 (46.1--104.6      

  **BMI (kg/m**^**2**^**)**              27.8±3.6\                 27.7±4.1\              25.6±3.1\              \<0.001 [^a^](#t001fn002){ref-type="table-fn"}^,^[^b^](#t001fn003){ref-type="table-fn"}^,^[^c^](#t001fn004){ref-type="table-fn"}
                                         27.4 (17.1--39.1)         27.5 (18.4--41.8)      25.5 (17.0--33.4)      

  **Waist circumference (cm)**           91.6±10.9\                90.2±11.5\             86.2±11.2\             \<0.001 [^b^](#t001fn003){ref-type="table-fn"}^,^[^c^](#t001fn004){ref-type="table-fn"}
                                         91.4 (67.0--121.3)        89.9 (61.3--113.7)     85.2 (62.7--124.7)     

  **Hip circumference (cm)**             102.6±8.1\                102.5±8.3\             99.2±6.7\              \<0.001 [^b^](#t001fn003){ref-type="table-fn"}^,^[^c^](#t001fn004){ref-type="table-fn"}
                                         102.0 (82.7--140.0)       102.0 (84--136.8)      99.1 (84.0--121.8)     

  **Energy (kcal/day)**                  1666±486\                 1650±438\              1778 ±492\             \<0.01[^b^](#t001fn003){ref-type="table-fn"}
                                         1618 (540.7--3121)        1603 (722--3154)       1722 (884--3515)       

  **Smoker**                             16 (12.0)                 6 (3.5)                12 (9.5)               \<0.05[^a^](#t001fn002){ref-type="table-fn"}

  **Education**                                                                                                  

  Primary school                         78 (58.6)                 30 (22.6)              25 (18.8)              \<0.05 [^a^](#t001fn002){ref-type="table-fn"}^,^[^b^](#t001fn003){ref-type="table-fn"}^,^[^c^](#t001fn004){ref-type="table-fn"}

  Secondary school                       68 (39.9)                 57 (34.1)              45 (26.0)              

  University graduate                    40 (31.8)                 41 (32.5)              45 (35.7)              

  **Current income**                                                                                             

  \<600 €/month                          43 (32.3)                 19 (14.3)              71 (53.4)              \<0.001 [^b^](#t001fn003){ref-type="table-fn"}^,^[^c^](#t001fn004){ref-type="table-fn"}

  600--900 €/month                       41 (24.1)                 23 (13.5)              106 (62.4)             

  \>900 €/month                          11 (8.7)                  17 (13.5)              98 (77.8)              

  **Systolic blood pressure (mm Hg)**    141.0±18.3\               140.3±17.6\            139.6±17.2\            \>0.05
                                         138.8 (93.5--219.5)       139.3 (100-213-5)      139.0 (104.5--185.5)   

  **Diastolic blood pressure (mm Hg)**   81.0±9.8\                 79.4±10.4\             77.5±8.1\              \<0.05[^a^](#t001fn002){ref-type="table-fn"}
                                         81.0 (54.5--108.5)        79.5 (50.0--126.0)     76.5 (58.0--102.0)     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as the means±SD; median (minimum-maximum); n, no. of subjects and values (%). BMI, body mass index. Comparisons between physical fitness groups were analyzed by one-way ANOVA or the Kruskal-Wallis test, according to the normality of the variables. *Post hoc* analyses were conducted with the Bonferroni adjustment.

^a^: Low fitness vs. medium fitness;

^b^: low fitness vs. high fitness;

^c^: medium fitness vs. high fitness.

Level of significance p\<0.05.

The descriptive data of biomarkers according to PF groups are shown in [Table 2](#pone.0206307.t002){ref-type="table"}. Blood levels of creatinine (p\<0.001), TC (p\<0.05), HDL-c (p\<0.001), LDL-c (p\<0.01), sfolate (p\<0.001) and RBC folate (p\<0.01) were significantly higher in the high PF group than in the low and medium PF groups. Participants from the high PF group also showed lower significant blood levels than those in the low and medium PF groups for total protein and TG concentrations (both p\<0.05).

10.1371/journal.pone.0206307.t002

###### Descriptive data of biomarkers divided by PF groups.

![](pone.0206307.t002){#pone.0206307.t002g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Biomarkers                           Physical fitness groups                                                                                      
  ------------------------------------ ------------------------- ---------------------- ----- ----------------------- ----- ----------------------- ---------
  **Glucose (mg/dL)**                  129                       99.5±15.7\             172   99.1±12.7\              126   98.1±14.8\              \>0.05
                                                                 96.0 (75.0--190.0)           98.0 (75.0--144.0)            97.0 (71.0--181.0)      

  **Urea (mg/dL)**                     130                       36.3±9.3\              171   37.5±8.2\               126   37.5±8.2\               \>0.05
                                                                 35.9 (19.0--69.0)            37.0 (20.0--59.8)             37.0 (17.7--62.2)       

  **Uric acid (mg/dL)**                130                       5.4±1.3\               171   5.4±1.4\                126   5.3±1.3\                \>0.05
                                                                 5.1 (2.8--9.4)               5.5 (2.6--9.4)                5.2 (3.0--8.9)          

  **Creatinine (mg/dL)**               131                       0.82±0.21\             172   0.86±0.17\              126   0.93±0.17\              \<0.001
                                                                 0.78 (0.53--2.18)            0.84 (0.57--1.46)             0.91 (0.64--1.41)       

  **Total protein (g/L)**              62                        70.4±3.6\              116   70.3±3.9\               97    69.0±3.7\               \<0.05
                                                                 70.0 (60.5--81.0)            70.0 (62.0--81.0)             69.0 (60.0--78.0)       

  **Albumin (g/L)**                    61                        42.2±2.1\              116   42.1±2.1\               97    42.0±2.5\               \>0.05
                                                                 42.0 (37.7--46.0)            42.0 (37.0--49.0)             42.0 (35.0--48.0)       

  **TC (mg/dL)**                       130                       204.0±35.3\            172   210.8±34.6\             126   218.4±33.3\             \<0.01
                                                                 198.5 (112.0--293.0)         206.0 (141.0--351.0)          219.0 (131.0--321.0)    

  **HDL-c (mg/dL)**                    129                       53.0±12.6\             169   55.8±13.1\              124   59.2±13.5\              \<0.001
                                                                 53.0 (20.0--91.0)            54.5 (27.7--95.2)             57.9 (32.6--98.0)       

  **LDL-c (mg/dL)**                    129                       129.7±30.1\            169   135.1±29.6\             124   141.3±27.4\             \<0.01
                                                                 126.0 (69.4--218.8)          134.0 (69.0--249.5)           142.7 (71.4--224.8)     

  **TG (mg/dL)**                       130                       104.3±38.4\            172   99.1±40.8\              126   93.9±37.9\              \<0.05
                                                                 97.2 (33.0--208.0)           90.1 (45.2--268.0)            84.1 (40.6--274.1)      

  **Hematocrit (%)**                   131                       43.4                   168   43.3                    125   43.1                    \>0.05

  **Hemoglobin (g/dL)**                131                       14.6±1.2\              168   14.5±1.1\               125   14.5±1.0\               \>0.05
                                                                 14.7 (12.0--17.0)            14.3 (12.0--18.0)             14.6 (12.0--17.0)       

  **FE (ug/dL)**                       61                        93.1±23.8\             115   91.6±33.9\              98    93.8±28.2\              \>0.05
                                                                 94.0 (38.2--137.5)           87.5 (38.3--331.0)            90.7 (45.4--201.2)      

  **FER (ng/dL)**                      60                        122.3±101.0\           115   125.5±99.5\             96    126.6±93.4\             \>0.05
                                                                 110.7 (12.0--671.5)          93.6 (13.0--542.0)            98.0 (16.8--419.3)      

  **tHcy (μmol /dL)**                  111                       13.4±4.6\              164   12.9±4.4\               124   12.3±4.0\               = 0.090
                                                                 12.8 (1.8--35.5)             12.2 (2.0--31.3)              11.6 (3.9--34.2)        

  **Vitamin B**~**12**~ **(pg/ mL)**   109                       375.8±181.2\           163   390.3±202.0\            124   386.4±172.4\            \>0.05
                                                                 345.3 (86.5--1163.0)         343.7 (122.8--1650.0)         350.2 (100.0--1402.0)   

  **sfolate (ng/ mL)**                 111                       10.1±4.2\              164   11.1±4.4\               124   11.9±4.2\               \<0.001
                                                                 8.8 (2.7--32.7)              10.4 (3.9--29.3)              11.7 (4.7--29.9)        

  **RBC folate (ng/ mL)**              91                        345.9±117.2\           133   369.2±114.5\            113   384.2±105.5\            \<0.01
                                                                 326.9 (156.1--728.8)         351.2 (184.2--862.6)          379.1 (149.0--710.0)    

  **Vitamin D (25(OH)D) (mg/mL)**      109                       25.6±10.3\             154   25.9±9.8\               120   26.0±10.5\              \>0.05
                                                                 24.1 (4.5--51.9)             25.4 (4.3--64.4)              25.5 (6.7--57.7)        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

Values are presented as the means±SD; n, median (minimum-maximum); no. of subjects. sfolate, serum folate; RBC folate; red blood cell folate; tHcy, total homocysteine; TC, total cholesterol; TG, triglycerides; HDL-c, HDL-cholesterol; LDL-c, LDL-cholesterol; FE, iron, FER, ferritin. Comparisons between physical fitness groups were analyzed by one-way ANOVA or the Kruskal-Wallis test, according to the normality of the variables. Level of significance p\<0.05.

[Fig 1](#pone.0206307.g001){ref-type="fig"} displays the percentage of each biomarker in and out of the reference range. A total of 67.9% and 58.6% of the sample presented low vitamin 25\[OH\]D concentrations and high TC concentrations, respectively, that were out of the reference range. Likewise, several blood markers including glucose (38.3%), uric acid (32.3%), LDL-c (27.7%) and tHcy (4.3%) that were higher than the reference range.

![Percentage of each biomarker in and out of the reference range.\
Values are presented as percentages (%). sfolate, serum folate; tHcy, total homocysteine; TC, total cholesterol; TG, triglycerides; HDL-c, HDL-cholesterol; LDL-c, LDL-cholesterol; FE, iron, FER, ferritin.](pone.0206307.g001){#pone.0206307.g001}

Results from the general linear model investigating the associations between blood biomarkers and PF groups are shown in [Table 3](#pone.0206307.t003){ref-type="table"}. Participants from the low PF group had lower vitamin B~12~ concentrations out of the reference range (both models, p\<0.05). However, participants in the low PF group showed greater tHcy concentrations out of the reference range than those from the high PF group (both models, p\<0.05). Furthermore, vitamin B~12~ deficiency and tHcy concentrations in males increased significantly in parallel with advanced age (p\<0.05). Likewise, high total protein concentrations out of reference range were observed in the low PF (both models, p\>0.05) and medium PF groups (both model, p\>0.05) compared to the high PF group. Participants from the low PF group also had a higher likelihood of having creatinine concentrations out of the reference range than those from the high PF group (both models, p\<0.001).

10.1371/journal.pone.0206307.t003

###### Association between biomarkers and physical fitness.

![](pone.0206307.t003){#pone.0206307.t003g}

  ------------------------------------------------------- --------- ------------- ----------------------------------- -------- -------------
  **Dependent variable: Creatinine (mg/dL)**                                                                                   
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    1.431     0.000         Male                                1.668    0.025
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.017     0.402         Age (y)                             0.017    0.433
  Low fitness                                             -1.323    0.000         Weight (kg)                         0.018    0.450
  Medium fitness                                          -0.696    0.062         Height (cm)                         0.009    0.763
  High fitness                                            0.000                   FFM (kg)                            -0.035   0.560
  Protein intake (g)                                      0.007     0.288         Low fitness                         -1.381   0.000
                                                                                  Medium fitness                      -0.727   0.057
                                                                                  High fitness                        0.000    
                                                                                  Protein intake (g)                  0.008    0.277
  **Dependent variable: Total protein (g/L)**                                                                                  
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    0.805     0.195         Male                                0.607    0.360
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.005     0.894         Age (y)                             0.038    0.364
  Low fitness                                             2.002     0.061         Low fitness                         2.058    0.063
  Medium fitness                                          1.039     0.069         Medium fitness                      1.048    0.082
  High fitness                                            0.000                   High fitness                        0.000    
  Protein intake (g)                                      0.026     0.737         GOT (U/L)                           -0.013   0.846
  Vegetal intake (g)                                      -0.050    0.539         GPT (U/L)                           0.030    0.066
  Animal intake (g)                                       0.004     0.955         GGT (U/L)                           -0.001   0.963
  **Dependent variable: Total cholesterol (mg/dL)**                                                                            
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    1.092     0.000         Male                                1.110    0.000
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.023     0.151         Age (y)                             0.025    0.125
  Low fitness                                             1.028     0.000         Low fitness                         1.036    0.000
  Medium fitness                                          0.546     0.038         Medium fitness                      0.600    0.025
  High fitness                                            0.000                   High fitness                        0.000    
  Total cholesterol intake (mg)                           0.000     0.473         Total cholesterol intake (mg)       0.000    0.629
                                                                                  SFA intake (g)                      -0.106   0.037
  No lipid-lowering drugs                                 -0.962    0.000         MUFA intake (g)                     -0.109   0.033
  Yes lipid-lowering drugs                                0.000                   PUFA intake (g)                     -0.148   0.025
                                                                                  Lipid intake (g)                    0.103    0.021
                                                                                  No lipid-lowering drugs             -0.973   0.000
                                                                                  Yes lipid-lowering drugs            0.000    
  **Dependent variable: HDL-cholesterol (mg/dL)**                                                                              
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -1.829    0.000         Male                                -1.964   0.000
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.002     0.910         Age (y)                             0.007    0.701
  Low fitness                                             -0.901    0.007         Low fitness                         -0.917   0.007
  Medium fitness                                          -0.391    0.231         Medium fitness                      -0.384   0.246
  High fitness                                            0.000                   High fitness                        0.000    
  Total cholesterol intake (mg)                           -0.001    0.375         Total cholesterol intake (mg)       -0.001   0.172
  No lipid-lowering drugs                                 -0.148    0.625         SFA intake (g)                      0.091    0.119
  Yes lipid-lowering drugs                                0.000                   MUFA intake (g)                     0.068    0.225
                                                                                  PUFA intake (g)                     0.025    0.723
                                                                                  Lipid intake (g)                    -0.054   0.272
                                                                                  No lipid-lowering drugs             -0.216   0.486
                                                                                  Yes lipid-lowering drugs            0.000    
  **Dependent variable: LDL-cholesterol (mg/dL)**                                                                              
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    0.297     0.158         Male                                0.240    0.262
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.026     0.132         Age (y)                             0.032    0.078
  Low fitness                                             0.563     0.051         Low fitness                         0.651    0.029
  Medium fitness                                          0.488     0.065         Medium fitness                      0.589    0.030
  High fitness                                            0.000                   High fitness                        0.000    
  Total cholesterol intake (mg)                           0.237     0.180         Total cholesterol intake (mg)       -0.002   0.064
  No lipid-lowering drugs                                 -1.090    0.001         SFA intake (g)                      -0.079   0.165
  Yes lipid-lowering drugs                                0.000                   MUFA intake (g)                     -0.129   0.024
                                                                                  PUFA intake (g)                     -0.015   0.904
                                                                                  Lipid intake (g)                    0.009    0.061
                                                                                  No lipid-lowering drugs             -1.130   0.001
                                                                                  Yes lipid-lowering drugs            0.000    
  **Dependent variable: Triglycerides (mg/dL)**                                                                                
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -0.436    0.056         Male                                -0.557   0.022
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.026     0.132         Age (y)                             0.006    0.745
  Low fitness                                             -0.720    0.013         Low fitness                         -0.694   0.020
  Medium fitness                                          -0.387    0.170         Medium fitness                      -0.312   0.274
  High fitness                                            0.000                   High fitness                        0.000    
  Total cholesterol intake (mg)                           0.000     0.803         Total cholesterol intake (mg)       -0.001   0.209
  No lipid-lowering drugs                                 0.437     0.079         SFA intake (g)                      -0.116   0.053
  Yes lipid-lowering drugs                                0.000                   MUFA intake (g)                     -0.166   0.007
                                                                                  PUFA intake (g)                     -0.123   0.104
                                                                                  Lipid intake (g)                    0.141    0.009
                                                                                  No lipid-lowering drugs             0.423    0.095
                                                                                  Yes lipid-lowering drugs            0.000    
  **Dependent variable: Total homocysteine (μmol /dL)**                                                                        
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -1.284    0.000         Male                                -1.287   0.000
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 -0.046    0.014         Age (y)                             -0.047   0.014
  Low fitness                                             -0.723    0.030         Low fitness                         -0.716   0.033
  Medium fitness                                          -0.334    0.283         Medium fitness                      -0.329   0.285
  High fitness                                            0.000                   High fitness                        0.000    
  Vitamin B~12~ intake (ug)                               0.035     0.080         Vitamin B~12~ intake (ug)           0.034    0.113
                                                                                  Folate intake (ug)                           
  Yes Renin-angiotensin system drug                       0.542     0.053         Yes Renin-angiotensin system drug   0.541    0.053
  No Renin-angiotensin system drug                        0.000                   No Renin-angiotensin system drug    0.000    
  Yes beta blocker                                        0.352     0.445         Yes beta blocker                    0.355    0.442
  No beta blocker                                         0.000                   No beta blocker                     0.000    
  **Dependent variable: Vitamin B**~**12**~ **(pg/mL)**                                                                        
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -0.747    0.004         Male                                -0.749   0.004
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 -0.053    0.006         Age (y)                             -0.053   0.005
  Low fitness                                             -0.847    0.020         Low fitness                         -0.757   0.028
  Medium fitness                                          -0.509    0.099         Medium fitness                      -0.539   0.091
  High fitness                                            0.000                   High fitness                        0.000    
  Protein intake (g)                                      0.005     0.468         Vitamin B~12~ intake (ug)           0.019    0.265
                                                                                  Folate intake (ug)                  0.000    0.692
  **Dependent variable: Glucose (mg/dL)**                                                                                      
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -10.962   0.002         Male                                -1.738   0.015
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 -0.019    0.245         Age (y)                             -0.012   0.492
  Low fitness                                             -0.433    0.282         Low fitness                         -0.275   0.513
  Medium fitness                                          -0.307    0423          Medium fitness                      -0.022   0.957
  High fitness                                            0.000                   High fitness                        0.000    
  Carbohydrate intake (g)                                 0.000     0.896         Weight (kg)                         0.064    0.185
  Mono & Disaccharides intake (g)                         0.004     0.616         BMI (kg/m^2^)                       -0.227   0.011
  Polysaccharides intake (g)                              -0.002    0.756         FFM (kg)                            -6-323   0.108
                                                                                  TBW (KG)                            8.634    0.108
  Yes antidiabetic drug                                   4.366     0.000         Yes antidiabetic drug               4.339    0.000
  No antidiabetic drug                                    0.000                   No antidiabetic drug                0.000    
  **Dependent variable: Uric acid (mg/dL)**                                                                                    
  **Model 1**                                             **β**     **p-value**                                                
  Male                                                    -2.249    0.000                                                      
  Female                                                  0.000                                                                
  Age (y)                                                 -0.005    0.783                                                      
  Low fitness                                             -0.135    0.663                                                      
  Medium fitness                                          -0.420    0.145                                                      
  High fitness                                            0.000                                                                
  Protein intake (g)                                      0.006     0.261                                                      
  **Dependent variable: Urea (mg/dL)**                                                                                         
  **Model 1**                                             **β**     **p-value**                                                
  Male                                                    -0.650    0.096                                                      
  Female                                                  0.000                                                                
  Age (y)                                                 -0.038    0.165                                                      
  Low fitness                                             -0.213    0.639                                                      
  Medium fitness                                          0.059     0.897                                                      
  High fitness                                            0.000                                                                
  Protein intake (g)                                      -0.018    0.005                                                      
  **Dependent variable: Hematocrit (%)**                                                                                       
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -2.568    0.000         Male                                -1.746   0.000
  Female                                                  0.000                   Female                              0.000    
  Low fitness                                             -0.429    0.249         Low fitness                         -0.608   0.195
  Medium fitness                                          -0.480    0.134         Medium fitness                      -0.497   0.211
  High fitness                                            0.000                   High fitness                        0.000    
                                                                                  Red blood cells (10\^6/mm3)         -5.559   0.000
  **Dependent variable: Hemoglobin (g/dL)**                                                                                    
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -2.408    0.000         Male                                -1.677   0.000
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.029     0.157         Age (y)                             0.028    0.221
  Low fitness                                             -0.575    0.100         Low fitness                         -0.527   0.171
  Medium fitness                                          -0.433    0.192         Medium fitness                      -0.434   0.232
  High fitness                                            0.000                   High fitness                        0.000    
                                                                                  Red blood cells (10\^6/mm3)         -3.137   0.000
  **Dependent variable: Iron (ug/dL)**                                                                                         
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    0.405     0.307         Male                                0.432    0.293
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 -0.010    0.714         Age (y)                             -0.012   0.660
  Low fitness                                             -0.176    0.729         Low fitness                         -0.326   0.528
  Medium fitness                                          -0.069    0.874         Medium fitness                      -0.204   0.646
  High fitness                                            0.000                   High fitness                        0.000    
  Iron intake (mg)                                        -0.008    0.163         B~12~ intake (mg)                   0.010    0.714
                                                                                  Folate intake (ug)                  -0.003   0.033
                                                                                  Iron intake (mg)                    -0.008   0.152
  **Dependent variable: Ferritin (ng/dL)**                                                                                     
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    -1.310    0.000         Male                                -1.336   0.000
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 -0.001    0.951         Age (y)                             0.000    0.986
  Low fitness                                             0.184     0.665         Low fitness                         0.211    0.626
  Medium fitness                                          0.067     0.843         Medium fitness                      0.073    0.831
  High fitness                                            0.000                   High fitness                        0.000    
  Iron intake (mg)                                        0.032     0.114         B~12~ intake (mg)                   0.010    0.641
                                                                                  Folate intake (ug)                  0.000    0.858
                                                                                  Iron intake (mg)                    0.029    0.149
                                                                                  Lipid intake (g)                    -0.053   0.284
  **Dependent variable: Serum folate (ng/mL)**                                                                                 
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    0.202     0.581         Male                                0.130    0.725
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.013     0.651         Age (y)                             0.015    0.586
  Low fitness                                             0.658     0.173         Low fitness                         0.632    0.192
  Medium fitness                                          0.343     0.387         Medium fitness                      0.372    0.350
  High fitness                                            0.000                   High fitness                        0.000    
  Folate intake (ug)                                      -0.001    0.240         Folate intake (ug)                  -0.001   0.202
                                                                                  Vitamin B~12~ intake (ug)           0.030    0.368
  **Dependent variable: RBC folate (ng/mL)**                                                                                   
  **Model 1**                                             **β**     **p-value**   **Model 2**                         **β**    **p-value**
  Male                                                    0.784     0.034         Male                                0.730    0.051
  Female                                                  0.000                   Female                              0.000    
  Age (y)                                                 0.018     0.479         Age (y)                             0.019    0.440
  Low fitness                                             0.051     0.904         Low fitness                         0.017    0.967
  Medium fitness                                          0.086     0.826         Medium fitness                      0.097    0.803
  High fitness                                            0.000                   High fitness                        0.000    
  Folate intake (ug)                                      -0.001    0.404         Folate intake (ug)                  -0.001   0.358
                                                                                  Vitamin B~12~ intake (ug)           0.017    0.496
  **Dependent variable: Vitamin D 25\[OH\]D (ng/mL)**                                                                          
  **Model 1**                                             **β**     **p-value**                                                
  Male                                                    0.235     0.300                                                      
  Female                                                  0.000                                                                
  Age (y)                                                 -0.016    0.351                                                      
  Low fitness                                             0.221     0.442                                                      
  Medium fitness                                          0.101     0.705                                                      
  High fitness                                            0.000                                                                
  Vitamin D intake (ug)                                   0.005     0.318                                                      
  Calcium intake (mg)                                     0.000     0.688                                                      
  ------------------------------------------------------- --------- ------------- ----------------------------------- -------- -------------

β; standardized coefficients. BMI; body mass index; FFM, fat free mass; SFA; saturated fatty acids; MUFA; mono-unsaturated fatty acids; PUFA; polyunsaturated fatty acids; GOT; Glutamic oxalacetic transaminase, GPT; Glutamic-pyruvic transaminase, GGT; Gamma glutamyl transpeptidase; RBC folate, red blood cell folate; TBW, total body water. Level of significance p\<0.05.

Concerning the blood lipid profile, more participants in the low PF group than in the high PF group had TC levels above the reference range (both models, p\<0.001). Males had higher concentrations of TC than females (p\<0.001). Additionally, when considering lipid and fatty acid intake in the model, these associations remained significant (p\<0.05). Similarly, participants from the low (both models, p\<0.001) and medium (both models, p\<0.05) PF groups had greater HDL-c concentrations out of the reference range than those from the high PF group. Considering drugs related to blood lipid modifications, participants who regularly consumed lipid-reducing drugs presented higher concentrations out of the reference range for TC and LDL-c than participants who did not take these drugs (both models, p\<0.01). In contrast, more individuals in the high PF group than in the low PF group had TG concentrations out of the reference range (both models, p\<0.05), and this significant association remained when lipids and monounsaturated fatty acids were considered as cofounders (model 2, p\<0.05).

Discussion {#sec012}
==========

This study has shown that there are significant associations between PF levels and several blood biomarkers related to disease risk. Our main results revealed that participants from the low PF group showed lower vitamin B~12~ and TG concentrations out of the reference range and higher concentrations out of the reference range for tHcy, creatinine, TC, HDL-c and LDL-c. A high percentage of the sample population presented also with low vitamin 25\[OH\]D and high TC, glucose, uric acid, LDL-c and tHcy concentrations independent of PF. To the best of the authors´ knowledge, there are no studies analyzing the relationship between blood biomarker concentrations within and out of the reference range and PF groups in Spanish older adults through this holistic approach. In this sense, participants who showed concentrations out of the reference range were also considered as having concentrations related to disease risk because long periods with biomarker levels out of the reference range could have a negative effect on health.

Regarding B-vitamins, subclinical deficiency and deficiency of these vitamins are common in the older adult population \[[@pone.0206307.ref015],[@pone.0206307.ref037]\], and both tend to increase with age \[[@pone.0206307.ref038]\]. A total of 51.8% of the studied population presented subclinical deficiency considering as a cut-off point a concentration less than 352.3 pg/mL \[[@pone.0206307.ref015]\] (data not shown). Severe vitamin B~12~ deficiency causes an irreversible degeneration of the nervous system. Vitamin B~12~ and folate are involved as coenzymes of numerous regulating enzymes \[[@pone.0206307.ref039]\].

The relationships among vitamin B~12~, sfolate, RBC folate and tHcy are an ongoing research areas, especially if PF and PA are considered \[[@pone.0206307.ref001]\]. Likewise, no single blood marker has been described that could effectively evaluate the aging process \[[@pone.0206307.ref040]\]. Surprisingly, participants from the low PF group had lower vitamin B~12~ concentrations out of the reference range. Additionally, participants included in the low PF group presented significantly high tHcy concentrations out of the reference range, but no association was found among sfolate and RBC folate and PF levels in our study. Joubert et al. indicated that participants from the active and high PF groups presented a significantly higher concentration of tHcy than the sedentary group, as measured by means of treadmill VO~2\ max~ \[[@pone.0206307.ref041]\]. Alomari et al. observed an inverse association between PA levels and tHcy. Additionally, they reported a lower concentration of tHcy in subjects with higher vs. lower PA adjusting for vitamin B~12~ \[[@pone.0206307.ref042]\]. In this sense, Murakami et al. also did not observe differences in tHcy after controlling for age, sex, and folate intake according to PA groups \[[@pone.0206307.ref043]\]. In our study, with advancing age (in males), vitamin B~12~ deficiency and tHcy concentrations increased. Kuo et al. observed that high tHcy concentrations were inversely associated with cardiovascular fitness in females but not in males \[[@pone.0206307.ref044]\]. Likewise, Schoor et al. observed that females in the highest quartile of tHcy had a significantly lower PF than those in the lowest quartile \[[@pone.0206307.ref012]\]. A recent systematic review suggested positive results of increasing folic acid and vitamin B~12~ supplementation and regular physical exercise to prevent hyperhomocysteinemia \[[@pone.0206307.ref045]\].

Vitamin D deficiency has been previously published in all age stages \[[@pone.0206307.ref024],[@pone.0206307.ref046],[@pone.0206307.ref047]\] and is still an unsolved public health problem. In our population, a total of 67.9% of participants presented vitamin D concentrations below 29.99 ng/mL. Vitamin D is considered a marker of improved muscle condition, mainly in healthy older adults with lower PA as measured by means of PA questionnaires \[[@pone.0206307.ref027]\]. Al-Eisa et al. found that participants with low PA showed significantly lower 25\[OH\]D serum concentrations than active participants \[[@pone.0206307.ref027]\]. However, in our study there was no association between PF groups and vitamin D.

Another interesting finding in our study was that the low PF group presented a higher risk of high TC, high LDL-c, low HDL-c and low TG concentrations out of the reference ranges than the high PF group. These results are in accordance with the findings of other authors \[[@pone.0206307.ref048],[@pone.0206307.ref049]\]. Furthermore, LDL-c and TG showed a significant relationship with PF groups when lipid intake was included into the statistical analysis but not with TC intake. These results confirm the relationship between lipid intake suggested by Siri-Tarino et al. \[[@pone.0206307.ref050]\]. Dvorak et al. observed that older adult subjects with high cardiorespiratory fitness, independent of their PA levels, presented lower concentrations of TG, TC, total HDL-c and low LDL-c \[[@pone.0206307.ref051]\].

In our study, uric acid and urea were analyzed, but there were not significant differences between PF groups, and there was also no association between PF and concentrations out of the reference range. These results could suggest that both blood biomarkers might increase after intensive exercise \[[@pone.0206307.ref001],[@pone.0206307.ref052],[@pone.0206307.ref053]\] but not as a consequence of performed PA during their lives. Low concentrations of total protein are associated with malnutrition \[[@pone.0206307.ref054]\]. A significant relationship was obtained between total protein and PF groups, and a major tendency for total protein concentrations out of the reference range was observed between low and medium PF groups compared to the high PF group. Furthermore, participants in the low PF group showed a significantly higher risk of presenting concentrations out of the reference range for creatinine than participants in the high PF group in our study.

Hematocrit, hemoglobin and red blood cells have been related to significant higher possibilities of adverse health-status measurements (i.e., multiple morbidities, cognitive impairment, disability and mortality) \[[@pone.0206307.ref055]\]. Nevertheless, in our study, we could not find these associations between hematocrit and hemoglobin and PF groups. This could be because similar concentrations were obtained in all PF groups. Low hematocrits have been observed in trained persons mainly due to an increased plasma volume \[[@pone.0206307.ref056]\].

Several biomarkers are key in biological pathways and have been related to cardiovascular disease, and it is clearly established that recurrent exercise modifies a wide number of blood biomarkers. Dietary intake was considered in the analysis due to its fundamental role in decreasing the progression of chronic disease \[[@pone.0206307.ref057]\].

The current study has some limitations. First, the cross-sectional design cannot determine the cause-effect relationship between PF and biomarkers. Second, all participants were volunteers; thus, the outcomes are applicable only for the study group. Despite the abovementioned limitations, the PHYSMED project has several strengths. Likewise, some results are well known (e.g., lipid markers); this study analyzed several blood markers, including PF as a health marker. Another strength is the inclusion of a battery of PF tests, which is a more objective and precise method than questionnaires. Additionally, clustering of PF produces an alternative approach to summarizing PF levels, and it allows a realistic, wide vision about behavioral patterns. Moreover, the strict standardization of the field work and the blood sample protocol among the cities that took part in the study was another strength.

In conclusion, the study shows new approaches regarding the relationship between blood biomarkers and different groups of PF. Blood markers of health were generally associated with high PF in Spanish older adults. Regular physical exercise modifies a broad variety of metabolic processes that are then reflected by particular variations in biomarkers; therefore, both PF and blood markers should be considered when analyzing health status in older subjects. The proposed blood markers could be used routinely considering also the PF groups, and public health strategies should be implemented regarding biomarkers at risk. Additionally, longitudinal studies are needed to predict the capabilities of blood markers according to PF.
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